155 related articles for article (PubMed ID: 25391430)
21. Persistently elevated soluble MHC class I polypeptide-related sequence A and transforming growth factor-β1 levels are poor prognostic factors in head and neck squamous cell carcinoma after definitive chemoradiotherapy.
Chen JL; Chang CC; Huang YS; Kuo HY; Chen TY; Wang CW; Kuo SH; Lin YL
PLoS One; 2018; 13(8):e0202224. PubMed ID: 30096190
[TBL] [Abstract][Full Text] [Related]
22. Serum transforming growth factor-beta1 and epidermal growth factor in biliary atresia.
Vejchapipat P; Theamboonlers A; Poomsawat S; Chittmittrapap S; Poovorawan Y
Eur J Pediatr Surg; 2008 Dec; 18(6):415-8. PubMed ID: 19012231
[TBL] [Abstract][Full Text] [Related]
23. Clinical significance of serum leptin level in patients with gastric cancer.
Tas F; Karabulut S; Erturk K; Duranyildiz D
Eur Cytokine Netw; 2018 Jun; 29(2):52-58. PubMed ID: 30078770
[TBL] [Abstract][Full Text] [Related]
24. Relation between transforming growth factor-β1 expression, its receptor and clinicopathological factors and survival in HER2-negative gastric cancers.
Ananiev J; Gulubova M; Tchernev G; Penkova M; Miteva R; Julianov A; Manolova I
Wien Klin Wochenschr; 2011 Nov; 123(21-22):668-73. PubMed ID: 22015652
[TBL] [Abstract][Full Text] [Related]
25. Clinical significance of serum caveolin-1 levels in melanoma patients.
Tas F; Karabulut S; Tilgen Yasasever C; Duranyildiz D
Int J Dermatol; 2016 May; 55(5):558-62. PubMed ID: 26084616
[TBL] [Abstract][Full Text] [Related]
26. Transforming growth factor beta 1 (TGF-β1) modulates Epstein-Barr virus reactivation in absence of Helicobacter pylori infection in patients with gastric cancer.
Shukla SK; Khatoon J; Prasad KN; Rai RP; Singh AK; Kumar S; Ghoshal UC; Krishnani N
Cytokine; 2016 Jan; 77():176-9. PubMed ID: 26239415
[TBL] [Abstract][Full Text] [Related]
27. Prognostic utility of circulating transforming growth factor beta 1 in breast cancer patients.
Dave H; Shah M; Trivedi S; Shukla S
Int J Biol Markers; 2012; 27(1):53-9. PubMed ID: 22020368
[TBL] [Abstract][Full Text] [Related]
28. Natural killer cell cytotoxicity and immunosuppressive cytokines (IL-10, TGF-beta1) in patients with gastric cancer.
Szkaradkiewicz A; Karpiński TM; Drews M; Borejsza-Wysocki M; Majewski P; Andrzejewska E
J Biomed Biotechnol; 2010; 2010():901564. PubMed ID: 20445748
[TBL] [Abstract][Full Text] [Related]
29. Transforming Growth Factor Beta 1 (TGF-β1) in Thyroid Cancer Patients: a View from the Peripheral Blood.
Zivancevic-Simonovic S; Mihaljevic O; Mihajlovic D; Milosevic-Djordjevic O; Jovanovic Z; Mijatovic-Teodorovic L; Colic M
Ann Clin Lab Sci; 2016 Jul; 46(4):401-6. PubMed ID: 27466300
[TBL] [Abstract][Full Text] [Related]
30. Transforming Growth Factor-β1 as a Predictor for the Development of Hepatocellular Carcinoma: A Nested Case-Controlled Study.
Watanabe Y; Iwamura A; Shimada YJ; Wakai K; Tamakoshi A; Iso H;
EBioMedicine; 2016 Oct; 12():68-71. PubMed ID: 27614396
[TBL] [Abstract][Full Text] [Related]
31. Serum levels of transforming growth factor-β1 (TGF-β1) in patients with systemic lupus erythematosus and Hashimoto's thyroiditis.
Manolova I; Gerenova J; Ivanova M
Eur Cytokine Netw; 2013 Mar; 24(1):69-74. PubMed ID: 23614931
[TBL] [Abstract][Full Text] [Related]
32. TNM staging for GIT cancers is correlated with the level of MMPs and TGF-β1.
El-Ashmawy NE; Khedr NF; Mansour MG; Al-Ashmawy GM
Clin Exp Med; 2020 Nov; 20(4):545-555. PubMed ID: 32772210
[TBL] [Abstract][Full Text] [Related]
33. [Relations of transforming growth factor-beta1 expression to differentiation and prognosis of advanced gastric cancer].
Guo RF; Zang SZ; Zhang L; Li WM; Hu FL; Lü YY
Zhonghua Yi Xue Za Zhi; 2006 Dec; 86(46):3249-54. PubMed ID: 17313802
[TBL] [Abstract][Full Text] [Related]
34. Clinical significance of serum caveolin-1 levels in gastric cancer patients.
Tas F; Karabulut S; Erturk K; Duranyildiz D
Exp Oncol; 2018 Dec; 40(4):323-327. PubMed ID: 30593761
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic role of serum interleukin-18 in gastric cancer patients.
Thong-Ngam D; Tangkijvanich P; Lerknimitr R; Mahachai V; Theamboonlers A; Poovorawan Y
World J Gastroenterol; 2006 Jul; 12(28):4473-7. PubMed ID: 16874857
[TBL] [Abstract][Full Text] [Related]
36. The Clinical Research of Serum VEGF, TGF-β1, and Endostatin in Non-small Cell Lung Cancer.
Liu SG; Yuan SH; Wu HY; Liu J; Huang CS
Cell Biochem Biophys; 2015 May; 72(1):165-9. PubMed ID: 25548002
[TBL] [Abstract][Full Text] [Related]
37. Platelet expression of transforming growth factor beta 1 is enhanced and associated with cardiovascular prognosis in patients with acute coronary syndrome.
Rath D; Chatterjee M; Müller I; Müller K; Böckmann C; Droppa M; Stimpfle F; Karathanos A; Borst O; Seizer P; Langer H; Schwab M; Gawaz M; Geisler T
Atherosclerosis; 2014 Dec; 237(2):754-9. PubMed ID: 25463116
[TBL] [Abstract][Full Text] [Related]
38. Clinical significance of serum and tissue Dickkopf-1 levels in patients with gastric cancer.
Lee HS; Lee HE; Park DJ; Kim HH; Kim WH; Park KU
Clin Chim Acta; 2012 Nov; 413(21-22):1753-60. PubMed ID: 22796372
[TBL] [Abstract][Full Text] [Related]
39. Serum Transforming Growth Factor-β1 Change After Neoadjuvant Chemoradiation Therapy Is Associated With Postoperative Pulmonary Complications in Esophageal Cancer Patients Undergoing Combined Modality Therapy.
Lu SL; Hsu FM; Tsai CL; Wu JK; Lee JM; Huang PM; Hsu CH; Koong AC; Chang DT; Cheng JC
Int J Radiat Oncol Biol Phys; 2015 Dec; 93(5):1023-31. PubMed ID: 26475065
[TBL] [Abstract][Full Text] [Related]
40. Elevated Levels of SET and MYND Domain-Containing Protein 3 Are Correlated with Overexpression of Transforming Growth Factor-β1 in Gastric Cancer.
Liu H; Liu Y; Kong F; Xin W; Li X; Liang H; Jia Y
J Am Coll Surg; 2015 Aug; 221(2):579-90. PubMed ID: 26077602
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
